Skip to main content
OpenTrials
Completed

NCT Number: NCT05403593

Registry of Emergent Large VeSsel OCclUsion DuE to IntraCranial AtherosclerosiS

The aim of this study is to develop an international multicenter registry of patient data and outcomes for patients undergoing mechanical thrombectomy for emergent large vessel occlusion with residual underlying stenosis following successful revascularization.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intracranial Stenosis Large Vessel Occlusion Mechanical Thrombectomy

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Universitätsmedizin Göttingen, Göttingen, Germany

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients undergoing mechanical thrombectomy
  • AND have intracranial stenosis
  • Patients aged 18-90 years

Exclusion criteria

  • None

Treatment and study plan

No intervention

Other

No intervention, prospective data collection

Primary outcomes

  1. modified Rankin score

    Time frame: pre-stroke

    standard stroke score measuring disability level delivered by physician with level 0-6 with 0 being no symptoms and 6 being death. Outcome measured by the distribution of mRS score.

  2. modified Rankin score

    Time frame: 7 days

    standard stroke score measuring disability level delivered by physician with level 0-6 with 0 being no symptoms and 6 being death. Outcome measured by the distribution of mRS score.

  3. modified Rankin score

    Time frame: admission

    standard stroke score measuring disability level delivered by physician with level 0-6 with 0 being no symptoms and 6 being death. Outcome measured by the distribution of mRS score.

  4. modified Rankin score

    Time frame: 3 months

    standard stroke score measuring disability level delivered by physician with level 0-6 with 0 being no symptoms and 6 being death. Outcome measured by the distribution of mRS score.

  5. Mortality

    Time frame: 90 day

    Death at 90 days post intervention

Sponsors and collaborators

Lead sponsor

Medical University of South Carolina

Other

Collaborators

  • Brown University
  • Careggi Hospital
  • Centro Hospitalar de Lisboa Central
  • Emory University
  • HCA Houston Healthcare Kingwood
  • Imam Abdulrahman Bin Faisal University
  • Indiana University
  • Massachusetts General Hospital
  • Sutter Health
  • The University of Texas Health Science Center at San Antonio
  • Thomas Jefferson University
  • University of Basel
  • University of Chicago
  • University of Göttingen
  • University of Iowa
  • University of Miami
  • University of Tennessee
  • Wake Forest University Health Sciences
  • Yale University
  • advocate christ medical center

Registry information

Acronym: RESCUE-ICAS

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Jun 3, 2022
Registry last updated
Sep 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.